[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:beauty-supplements-by-cellcare-bv-87137577:header:guest:personal:":3,"case:beauty-supplements-by-cellcare-bv-87137577:overview:guest:personal::{}":66},{"id":4,"slug":5,"name":6,"trade_names":7,"status":9,"procedure":10,"procedure_type":11,"insolvency_number":30,"case_number":30,"declared_on":31,"terminated_on":15,"termination_reason":15,"kvk_number":32,"legal_form":33,"sbi":15,"court":36,"judge":39,"judge_source":40,"curator":41,"location":45,"counts":55,"follower_count":59,"report_count":56,"last_report_on":60,"last_update_at":61,"freshness":62},"01M3S9QRAC5GAZTSMPZ2Z1M10Z","beauty-supplements-by-cellcare-bv-87137577","Beauty Supplements by CellCare B.V.",[8],"Beauty by CellCare","active","bankruptcy",{"id":12,"key":10,"family":13,"name":14,"short_name":15,"legal_basis":16,"features":20},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":17,"provision":18,"url":19},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[21,22,23,24,25,26,27,28,29],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.05\u002F24\u002F385","2024-09-19","87137577",{"value":34,"source":35},"BV","cir",{"name":37,"slug":38,"location":15},"Rechtbank Gelderland","gelderland","mr. O. Nijhuis",{"type":35,"report_number":15,"published_on":15},{"name":42,"slug":43,"law_firm":15,"city":15,"verified":44},"mr. F.W. Aartsen","fw-aartsen",false,{"street":46,"house_number":47,"addition":48,"postal_code":49,"city":50,"municipality":50,"province":51,"lat":52,"lng":53,"kind":54,"source":35},"Ohmstraat","3","a","3861NB","Nijkerk","Gelderland",52.22939,5.478924,"business",{"reports":56,"documents":57,"assets":58,"investigations":59,"news":59},14,17,9,0,"2026-09-08","2026-10-04T17:25:14+00:00",{"last_checked_at":63,"last_reconciled_at":64,"stale":44,"status":65},"2026-10-07T17:21:12+00:00","2026-10-01T14:12:55+00:00","current",{"data":67},{"summary":68,"changes":115,"kpis":214,"topics":247,"topics_report_number":122,"topics_report_date":60,"processing":15,"timeline":329,"documents":384,"sources":396,"curator_update":15,"news":398,"auctions":399},{"kind":69,"category":69,"sentences":70,"facts":90,"published_at":114},"automated",[71,77,84],{"text":72,"facts":73},"Het faillissement van Beauty Supplements by CellCare B.V. is op 19 september 2024 uitgesproken door de Rechtbank Gelderland; curator is mr. F.W. Aartsen.",[74,75,76],"company","procedure","curator",{"text":78,"facts":79},"Volgens het verslag van 8 september 2026 bedraagt het boedelactief € 94.796,07, terwijl er 3 concurrente crediteuren zijn met vorderingen van € 1.226.460,29 en preferente vorderingen van € 9.091.",[80,81,82,83],"value_estate_assets","value_concurrent_claims","value_creditor_count","value_preferential_claims",{"text":85,"facts":86},"Volgens het verslag van 8 september 2026 is het onderzoek naar onbehoorlijk bestuur en paulianeus handelen afgerond, terwijl het onderzoek naar de boekhoudplicht nog loopt.",[87,88,89],"topic_bookkeeping_duty","topic_director_liability","topic_paulianas",{"company":91,"procedure":93,"curator":94,"reports":95,"value_estate_assets":96,"value_concurrent_claims":99,"value_creditor_count":102,"value_preferential_claims":105,"topic_bookkeeping_duty":108,"topic_director_liability":110,"topic_paulianas":112},{"category":92},"official",{"category":92},{"category":92},{"category":92},{"category":69,"value_id":97,"reference_id":98},31890,348848,{"category":69,"value_id":100,"reference_id":101},7759,79315,{"category":69,"value_id":103,"reference_id":104},28362,294020,{"category":69,"value_id":106,"reference_id":107},7760,294021,{"category":69,"topic_id":109},23629,{"category":69,"topic_id":111},23631,{"category":69,"topic_id":113},23632,"2026-10-04T04:51:36+00:00",{"from":116,"to":120,"count":123,"groups":124},{"id":117,"number":118,"published_on":119},"01M3S9RA93YV0PSHA2FP5VNXKC",6,"2026-01-28",{"id":121,"number":122,"published_on":60},"01M3S9RDE2KB5RK6KHWET261GT",7,5,{"new":125,"changed":126,"completed":178,"ongoing":199,"no_longer_mentioned":213},[],[127,152,166],{"kind":128,"field":129,"change":130,"from":131,"to":134,"delta":136,"delta_ratio":137,"source":138},"amount","preferential_claims","changed",{"value":132,"state":133,"qualifier":15},108548,"known",{"value":135,"state":133,"qualifier":15},9091,-99457,-0.9162,{"id":107,"category":69,"method":139,"source_type":140,"document":141,"page":147,"section":148,"excerpt":149,"certainty":150,"curator_verified_at":15,"processed_at":151},"deterministic","cir_report",{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"01M3S9RF52S7VCP5WE000GMWY9","Verslag:  08-09-2026",25,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3S9RF52S7VCP5WE000GMWY9.pdf",true,22,"8.2 Pref. vord. van de fiscus","€ 9.091,00 Toelichting Verslag 7 Na het indienen van bezw aarschriften en herhaaldelijk overleg met de Belastingdienst, zijn meerdere aanslagen Omzetbelasting van de Fiscale Eenheid verminderd en\u002Fof vernietigd.",0.95,"2026-10-02T18:15:07+00:00",{"kind":128,"field":153,"change":130,"from":154,"to":156,"delta":158,"delta_ratio":159,"source":160},"concurrent_claims",{"value":155,"state":133,"qualifier":15},14527.29,{"value":157,"state":133,"qualifier":15},1226460.29,1211933,83.4246,{"id":101,"category":69,"method":139,"source_type":140,"document":161,"page":162,"section":163,"excerpt":164,"certainty":150,"curator_verified_at":15,"processed_at":165},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},23,"8.6 Bedrag concurrente crediteuren","01-11-2024 € 14.527,29 1 08-09-2026 € 1.226.460,29 7","2026-09-30T13:58:41+00:00",{"kind":167,"field":168,"change":130,"from":169,"to":171,"delta":173,"delta_ratio":173,"source":174},"count","creditor_count",{"value":170,"state":133,"qualifier":15},1,{"value":172,"state":133,"qualifier":15},3,2,{"id":104,"category":69,"method":139,"source_type":140,"document":175,"page":162,"section":176,"excerpt":177,"certainty":150,"curator_verified_at":15,"processed_at":151},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"8.5 Aantal concurrente crediteuren","3 Toelichting Verslag 7 Uit onderzoek in de administratie van de gefailleerde vennootschap is gebleken dat zow el CellCare Health Group als Cell Care Philosophy in Supplements een vordering uit hoofde van de rekening-courantverhouding hebben op de gefailleerde vennootschap.",[179,191],{"kind":180,"topic":181,"change":182,"from":183,"to":182,"source":184},"topic","director_liability","completed","investigating",{"id":185,"category":69,"method":139,"source_type":140,"document":186,"page":187,"section":188,"excerpt":189,"certainty":190,"curator_verified_at":15,"processed_at":151},294031,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},19,"7.5 Onbehoorlijk bestuur","Nee Toelichting Verslag 7 De curator is niet gebleken van onbehoorlijk bestuur, dat heeft geleid tot het faillissement. De curator heeft zijn onderzoek afgerond.",0.7,{"kind":180,"topic":192,"change":182,"from":183,"to":182,"source":193},"paulianas",{"id":194,"category":69,"method":139,"source_type":140,"document":195,"page":196,"section":197,"excerpt":198,"certainty":190,"curator_verified_at":15,"processed_at":151},294032,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},20,"7.6 Paulianeus handelen","Nee Toelichting Verslag 7 De curator is niet gebleken van paulianeus verrichte rechtshandelingen. De curator heeft zijn onderzoek afgerond.",[200,208],{"kind":180,"topic":201,"change":202,"from":183,"to":183,"source":203},"bookkeeping_duty","ongoing",{"id":204,"category":69,"method":139,"source_type":140,"document":205,"page":57,"section":206,"excerpt":207,"certainty":190,"curator_verified_at":15,"processed_at":165},79340,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"7.1 Boekhoudplicht","Verslag 1 01-11-2024 De curator heeft met tussenkomst van Insolvit de boekhouding en 1 administratie veilig gesteld en zal, zoals in elk faillissement, deze aan een onderzoek onderw erpen. Verslag 2 31-01-2025 In onderzoek. 2",{"kind":180,"topic":209,"change":202,"from":183,"to":183,"source":210},"legality_review",{"id":211,"category":69,"method":139,"source_type":140,"document":212,"page":57,"section":206,"excerpt":207,"certainty":190,"curator_verified_at":15,"processed_at":165},79348,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},[],{"values":215,"reports":246},[216,231,235,239,243],{"field":217,"kind":128,"value":218,"state":133,"qualifier":15,"as_of":60,"category":69,"report_number":122,"report_date":60,"source":219,"previous":228,"delta":230,"curator":15,"processing":44,"correction_pending":44,"conflict":15},"estate_assets",94796.07,{"id":98,"category":69,"method":139,"source_type":140,"document":220,"page":118,"section":225,"excerpt":226,"certainty":150,"curator_verified_at":15,"processed_at":227},{"id":221,"title":222,"report_number":122,"report_date":60,"published_on":60,"page_count":223,"url":224,"available":146},"01M3S9RDDEPCY3TVPCBQ9C8744","Financieel verslag  08-09-2026",10,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3S9RDDEPCY3TVPCBQ9C8744.pdf","financial_statement_a","Totaal baten                                  € 94.796,07                       € 0,00","2026-10-03T06:31:11+00:00",{"value":229,"state":133,"report_number":118,"report_date":119},93578.23,1217.84,{"field":153,"kind":128,"value":157,"state":133,"qualifier":15,"as_of":60,"category":69,"report_number":122,"report_date":60,"source":232,"previous":234,"delta":158,"curator":15,"processing":44,"correction_pending":44,"conflict":15},{"id":101,"category":69,"method":139,"source_type":140,"document":233,"page":162,"section":163,"excerpt":164,"certainty":150,"curator_verified_at":15,"processed_at":165},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"value":155,"state":133,"report_number":118,"report_date":119},{"field":129,"kind":128,"value":135,"state":133,"qualifier":15,"as_of":60,"category":69,"report_number":122,"report_date":60,"source":236,"previous":238,"delta":136,"curator":15,"processing":44,"correction_pending":44,"conflict":15},{"id":107,"category":69,"method":139,"source_type":140,"document":237,"page":147,"section":148,"excerpt":149,"certainty":150,"curator_verified_at":15,"processed_at":151},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"value":132,"state":133,"report_number":118,"report_date":119},{"field":168,"kind":167,"value":172,"state":133,"qualifier":15,"as_of":60,"category":69,"report_number":122,"report_date":60,"source":240,"previous":242,"delta":173,"curator":15,"processing":44,"correction_pending":44,"conflict":15},{"id":104,"category":69,"method":139,"source_type":140,"document":241,"page":162,"section":176,"excerpt":177,"certainty":150,"curator_verified_at":15,"processed_at":151},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"value":170,"state":133,"report_number":118,"report_date":119},{"field":244,"kind":167,"value":15,"state":245,"qualifier":15,"as_of":15,"category":15,"report_number":15,"report_date":15,"source":15,"previous":15,"delta":15,"curator":15,"processing":44,"correction_pending":44,"conflict":15},"employee_count","not_mentioned",{"count":56,"next":15},[248,257,265,272,279,287,295,302,305,312,315,318,326],{"topic":249,"investigation":44,"state":250,"category":69,"source":251},"lease_contracts","mentioned",{"id":252,"category":69,"method":139,"source_type":140,"document":253,"page":122,"section":254,"excerpt":255,"certainty":256,"curator_verified_at":15,"processed_at":165},79319,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"1.4 Huur","Verslag 1 01-11-2024 CellCare Health Group huurde een kantoorruimte met magazijnruimte aan de 1 Ohmstraat 3 a te Nijkerk, w aarvan alle gefailleerde vennootschappen gebruik maakten. De curator zal met de verhuurder in overleg treden over beëindiging van de huurovereenkomst en ontruiming van het gehuurde. Verslag 3 30-04-2025 De huurovereenkomst met betrekking tot de bedrijfsruimte aan de Ohmstraat",0.5,{"topic":258,"investigation":146,"state":250,"category":69,"source":259},"causes_investigation",{"id":260,"category":69,"method":139,"source_type":140,"document":261,"page":262,"section":263,"excerpt":264,"certainty":256,"curator_verified_at":15,"processed_at":151},294026,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},8,"1.5 Oorzaak faillissement","Verslag 6 In de verslagperiode heeft de curator antw oorden van de directie van de 6 gefailleerde vennootschap ontvangen en gesproken met één van de voormalig bestuurders van de gefailleerde vennootschap. De curator is in afw achting van nadere documenten ter onderbouw ing van door de directie ingenomen stellingen.",{"topic":266,"investigation":44,"state":250,"category":69,"source":267},"employees",{"id":268,"category":69,"method":139,"source_type":140,"document":269,"page":58,"section":270,"excerpt":271,"certainty":256,"curator_verified_at":15,"processed_at":165},79322,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 19-9-2024 13 totaal 13",{"topic":273,"investigation":44,"state":250,"category":69,"source":274},"asset_sales",{"id":275,"category":69,"method":139,"source_type":140,"document":276,"page":58,"section":277,"excerpt":278,"certainty":256,"curator_verified_at":15,"processed_at":165},79323,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"3.1 Onroerende zaken","Toelichting onroerende zaken Verslag 1 01-11-2024 De gefailleerde vennootschappen hadden geen onroerende zaken in 1 eigendom.",{"topic":280,"investigation":44,"state":250,"category":69,"source":281},"receivables_collection",{"id":282,"category":69,"method":139,"source_type":140,"document":283,"page":284,"section":285,"excerpt":286,"certainty":256,"curator_verified_at":15,"processed_at":151},294028,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},11,"4.1 Debiteuren","Verslag 7 In de verslagperiode zijn de van debiteuren ontvangen betalingen bijgeschreven op de faillissementsrekening.",{"topic":288,"investigation":44,"state":250,"category":69,"source":289},"security_rights",{"id":290,"category":69,"method":139,"source_type":140,"document":291,"page":292,"section":293,"excerpt":294,"certainty":256,"curator_verified_at":15,"processed_at":165},79333,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},13,"5.3 Beschrijving zekerheden","Verslag 1 01-11-2024 Tot zekerheid van de terugbetaling van de door de Rabobank verstrekte 1 kredietfaciliteit zijn de volgende zekerheiden gevestigd; Hoofdelijke aansprakelijkheid van CellCare Health Group, Cell Care Philosophy in Supplements, CellCare Academy en KGM Health B.V.; Pandrecht op alle huidige en toekomstige inventarisgoederen van CellCare Health Group, Cell Care Philosophy in Supplem",{"topic":296,"investigation":44,"state":250,"category":69,"source":297},"going_concern",{"id":298,"category":69,"method":139,"source_type":140,"document":299,"page":57,"section":300,"excerpt":301,"certainty":256,"curator_verified_at":15,"processed_at":165},79339,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"6.8 Werkzaamheden doorstarten onderneming","Verslag 1 01-11-2024 De curator heeft een informatiememorandum opgesteld en verspreid, vragen 1 beantw oord van kandidaat kopers en daarmee onderhandelingen gevoerd. Uiteindelijk heeft de curator transactiedocumentatie opgesteld en uitonderhandeld.",{"topic":201,"investigation":146,"state":183,"category":69,"source":303},{"id":204,"category":69,"method":139,"source_type":140,"document":304,"page":57,"section":206,"excerpt":207,"certainty":190,"curator_verified_at":15,"processed_at":165},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"topic":306,"investigation":146,"state":250,"category":69,"source":307},"annual_accounts_filing",{"id":308,"category":69,"method":139,"source_type":140,"document":309,"page":57,"section":310,"excerpt":311,"certainty":256,"curator_verified_at":15,"processed_at":151},294030,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},"7.2 Depot jaarrekeningen","Verslag 1 Van CellCare Health Group is de jaarrekening over boekjaar 2020 eerst op 1 juni 2022 gedeponeerd, aldus te laat. Van Cell Care Philosophy in Supplements is de jaarrekening over boekjaar 2020 eveneens te laat gedeponeerd, op 1 juni 2022. De gefailleerde vennootschap Beauty Supplements by CellCare is op 28 juli 2022 opgericht en daarvan liep het eerste boekjaar tot 31 december 2023. Een ja",{"topic":181,"investigation":146,"state":182,"category":69,"source":313},{"id":185,"category":69,"method":139,"source_type":140,"document":314,"page":187,"section":188,"excerpt":189,"certainty":190,"curator_verified_at":15,"processed_at":151},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"topic":192,"investigation":146,"state":182,"category":69,"source":316},{"id":194,"category":69,"method":139,"source_type":140,"document":317,"page":196,"section":197,"excerpt":198,"certainty":190,"curator_verified_at":15,"processed_at":151},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},{"topic":319,"investigation":146,"state":250,"category":69,"source":320},"proceedings",{"id":321,"category":69,"method":139,"source_type":140,"document":322,"page":323,"section":324,"excerpt":325,"certainty":256,"curator_verified_at":15,"processed_at":165},79344,{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},24,"9.1 Naam wederpartijen","Verslag 1 01-11-2024 Niet van toepassing. 1",{"topic":209,"investigation":146,"state":183,"category":69,"source":327},{"id":211,"category":69,"method":139,"source_type":140,"document":328,"page":57,"section":206,"excerpt":207,"certainty":190,"curator_verified_at":15,"processed_at":165},{"id":142,"title":143,"report_number":122,"report_date":60,"published_on":60,"page_count":144,"url":145,"available":146},[330,340,345,363,371],{"id":331,"type":332,"group":75,"category":92,"occurred_at":333,"detected_at":334,"date_basis":335,"payload":336,"source":15},"01M3S9QRC1EJ464ADBT8VAG97J","publication_added","2026-09-14T00:00:00+00:00","2026-09-30T13:58:17+00:00","source",{"publication_id":337,"type":338,"description":339},"01M3S9QRBDTFF3Q8M5P1C2FVY7","creditor_meeting","Pro forma verificatievergadering op 22 oktober 2026 om 13:30",{"id":341,"type":332,"group":75,"category":92,"occurred_at":333,"detected_at":334,"date_basis":335,"payload":342,"source":15},"01M3S9QRBPHNGCW9RYCTXXJXAC",{"publication_id":343,"type":338,"description":344},"01M3S9QRBC2KS0B6M4RWQ6W5KM","Verificatievergadering op 22 oktober 2026 om 13:30",{"id":346,"type":347,"group":348,"category":69,"occurred_at":349,"detected_at":61,"date_basis":335,"payload":350,"source":15},"01M43Z5JCVD5MGZ042BSC8VX7A","financial_changed","financial","2026-09-08T12:00:00+00:00",{"from_report":351,"to_report":352,"from_number":118,"to_number":122,"from_date":119,"to_date":60,"fields":353},"01M3S9R8HJQVP4NS2NC67D6YT2","01M3S9RC1YHH2GHDDCCT8CP18F",[354,357],{"field":217,"from":355,"to":356,"delta":230},{"value":229,"state":133,"qualifier":15},{"value":218,"state":133,"qualifier":15},{"field":358,"from":359,"to":361,"delta":230},"estate_account_balance",{"value":360,"state":133,"qualifier":15},71770.41,{"value":362,"state":133,"qualifier":15},72988.25,{"id":364,"type":365,"group":25,"category":69,"occurred_at":349,"detected_at":151,"date_basis":335,"payload":366,"source":15},"01M3YX7FB23YH3HTZ1V7Q1CAD1","topic_changed",{"from_report":117,"to_report":121,"from_number":367,"to_number":56,"from_date":119,"to_date":60,"topics":368},12,[369,370],{"topic":181,"change":182,"from":183,"to":182},{"topic":192,"change":182,"from":183,"to":182},{"id":372,"type":347,"group":348,"category":69,"occurred_at":349,"detected_at":151,"date_basis":335,"payload":373,"source":15},"01M3YX7FB0B96NBG2NN8JN7B8R",{"from_report":117,"to_report":121,"from_number":367,"to_number":56,"from_date":119,"to_date":60,"fields":374},[375,378,381],{"field":129,"from":376,"to":377,"delta":136},{"value":132,"state":133,"qualifier":15},{"value":135,"state":133,"qualifier":15},{"field":153,"from":379,"to":380,"delta":158},{"value":155,"state":133,"qualifier":15},{"value":157,"state":133,"qualifier":15},{"field":168,"from":382,"to":383,"delta":173},{"value":170,"state":133,"qualifier":15},{"value":172,"state":133,"qualifier":15},[385,390,393,395],{"kind":386,"id":343,"title":344,"report_number":15,"date":387,"pages":15,"category":92,"url":15,"publication_type":338,"publication_number":388,"stored_at":334,"download_url":389},"publication","2026-09-14","05.gel.24.385.F.1309.1.26","http:\u002F\u002F127.0.0.1\u002Fapi\u002Fcases\u002Fbeauty-supplements-by-cellcare-bv-87137577\u002Fpublications\u002F01M3S9QRBC2KS0B6M4RWQ6W5KM\u002Fdownload",{"kind":386,"id":337,"title":339,"report_number":15,"date":387,"pages":15,"category":92,"url":15,"publication_type":338,"publication_number":391,"stored_at":334,"download_url":392},"05.gel.24.385.F.1325.1.26","http:\u002F\u002F127.0.0.1\u002Fapi\u002Fcases\u002Fbeauty-supplements-by-cellcare-bv-87137577\u002Fpublications\u002F01M3S9QRBDTFF3Q8M5P1C2FVY7\u002Fdownload",{"kind":394,"id":142,"title":143,"report_number":122,"report_date":60,"date":60,"pages":144,"category":92,"url":145},"report",{"kind":394,"id":221,"title":222,"report_number":122,"report_date":60,"date":60,"pages":223,"category":92,"url":224},{"official":57,"curator":59,"automated":397,"external":59},134,[],[]]